Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Gastrointestinal motility and disorders, and Pregnancy and Medication Impact.
Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas-Sensing Wireless Motility Capsules.
Factors Associated With Loss of Fecal Biomarker Accuracy During Routine Assessment of Inflammatory Bowel Disease.
Incidence, prevalence and mortality of inflammatory bowel disease in New Zealand 2006-2022 using hospital information in the Integrated Data Infrastructure (IDI).
Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study.
Global evolution of inflammatory bowel disease across epidemiologic stages
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease.
Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018-2023.
Myeloperoxidase Enzyme Activity in Feces Reflects Endoscopic Severity in Inflammatory Bowel Disease.
Compounding Prevalence of Inflammatory Bowel Disease in a 2024 Population-Based Study From Canterbury, New Zealand.
Laxative use and chronic diarrhoea in older adults living in residential care.
Author's Response to Comment on "Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease".
20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand.
Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial.
Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to target.
The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence.
Review article: Telecare in gastroenterology-Within the COVID-19 pandemic and beyond.
Effects of Defatted Rice Bran-Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial.
Advancing microbiome research in Māori populations: insights from recent literature exploring the gut microbiomes of underrepresented and Indigenous peoples.
Ten-year outcomes of a prospective population-based incidence cohort of inflammatory bowel disease patients from Canterbury, New Zealand.
Assessing disease severity in inflammatory bowel disease - Can we reliably encompass the full burden of illness?
Effects of Defatted Rice Bran–Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial (Preprint)
Impact of Mānuka Honey on Symptoms and Quality of Life in Individuals With Functional Dyspepsia: Protocol for a Feasibility Randomized Controlled Trial (Preprint)
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries